Status:

COMPLETED

The Role of Tea Catechins and Caffeine in Relation to Energy Metabolism

Lead Sponsor:

University of Copenhagen

Collaborating Sponsors:

Unilever R&D

Conditions:

Obesity

Eligibility:

MALE

18-40 years

Phase:

NA

Brief Summary

The aim of this study is to elucidate the role of specific catechins, a mixture of catechins and caffeine in relation to weight control with particular emphasis on energy metabolism and fat oxidation.

Detailed Description

Obesity is the result of an imbalance between energy intake (EI) and energy expenditure (EE). Thus, two ways to treat obesity are to reduce EI or increase EE. Bioactive food ingredients affecting ener...

Eligibility Criteria

Inclusion

  • Healthy men
  • Age 18-40 years
  • BMI 18,5-25 kg/m2

Exclusion

  • Diabetes or any other endocrinological disease
  • Hypertensive medication
  • Increased Blood Pressure \> 140/85
  • Hyperlpidimia
  • Chronic disease (i.e. HIV)
  • Use of any diet supplements including vitamins (during and 3 months prior to the study).
  • High alcohol intake (\>21 units a week)
  • High caffeine intake (\>250 mg/day) or high catechin intake (\>200 mg/day)
  • Smoking
  • Elite sports performer
  • Use of any regular medication

Key Trial Info

Start Date :

November 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2006

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT00611416

Start Date

November 1 2005

End Date

February 1 2006

Last Update

February 9 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Human Nutrition, The Royal Veterinary and Agricultrual University

Frederiksberg C, Denmark, 1958